- Home
- LNTH vs DRS Comparison
LNTH vs DRS Comparison
Compare LNTH & DRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- DRS
- Stock Information
- Founded
- LNTH 1956
- DRS 1969
- Country
- LNTH United States
- DRS United States
- Employees
- LNTH N/A
- DRS N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- DRS Military/Government/Technical
- Sector
- LNTH Health Care
- DRS Industrials
- Exchange
- LNTH Nasdaq
- DRS Nasdaq
- Market Cap
- LNTH 7.5B
- DRS 8.3B
- IPO Year
- LNTH 2015
- DRS N/A
- Fundamental
- Price
- LNTH $73.86
- DRS $41.04
- Analyst Decision
- LNTH Strong Buy
- DRS Buy
- Analyst Count
- LNTH 5
- DRS 6
- Target Price
- LNTH $133.80
- DRS $38.33
- AVG Volume (30 Days)
- LNTH 1.5M
- DRS 1.0M
- Earning Date
- LNTH 05-07-2025
- DRS 05-01-2025
- Dividend Yield
- LNTH N/A
- DRS 0.44%
- EPS Growth
- LNTH N/A
- DRS 25.90
- EPS
- LNTH 3.53
- DRS 0.88
- Revenue
- LNTH $1,536,699,000.00
- DRS $3,345,000,000.00
- Revenue This Year
- LNTH $4.63
- DRS $9.89
- Revenue Next Year
- LNTH $9.35
- DRS $5.99
- P/E Ratio
- LNTH $20.92
- DRS $46.74
- Revenue Growth
- LNTH 12.53
- DRS 13.58
- 52 Week Low
- LNTH $73.11
- DRS $22.73
- 52 Week High
- LNTH $126.89
- DRS $43.40
- Technical
- Relative Strength Index (RSI)
- LNTH 26.09
- DRS 60.72
- Support Level
- LNTH $73.11
- DRS $40.12
- Resistance Level
- LNTH $81.50
- DRS $43.40
- Average True Range (ATR)
- LNTH 3.44
- DRS 1.33
- MACD
- LNTH -1.23
- DRS -0.28
- Stochastic Oscillator
- LNTH 2.10
- DRS 43.68
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About DRS Leonardo DRS Inc.
Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.